Bupropion
08-0178
Approved small_molecule completed
Quick answer
Bupropion for Attention Deficit Hyperactivity Disorder is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Attention Deficit Hyperactivity Disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed